GM, B., MC, V., S, B., A, P., S, P., & GL, C. (2026). Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: Drug utilization and patient characteristics. Global & regional health technology assessment, 13, 167. https://doi.org/10.33393/grhta.2026.3790
Chicago Style (17th ed.) CitationGM, Bruno, Valentino MC, Buda S, Paciello A, Palcic S, and Colombo GL. "Impact of AIFA Note 100 on Innovative Antidiabetic Prescribing Eligibility in Two Italian Local Health Authorities: Drug Utilization and Patient Characteristics." Global & Regional Health Technology Assessment 13 (2026): 167. https://doi.org/10.33393/grhta.2026.3790.
MLA (9th ed.) CitationGM, Bruno, et al. "Impact of AIFA Note 100 on Innovative Antidiabetic Prescribing Eligibility in Two Italian Local Health Authorities: Drug Utilization and Patient Characteristics." Global & Regional Health Technology Assessment, vol. 13, 2026, p. 167, https://doi.org/10.33393/grhta.2026.3790.